Biaryl pde4 inhibitors for treating pulmonary and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/16 (2006.01) C07D 213/06 (2006.01) C07D 213/64 (2006.01) C07D 213/74 (2006.01) C07D 213/75 (2006.01) C07D 213/79 (2006.01) C07D 213/84 (2006.01) C07D 231/12 (2006.01) C07D 239/42 (2006.01) C07D 285/135 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 471/04 (2006.01) C07D 473/18 (2006.01) C07D 473/40 (2006.01)

Patent

CA 2722611

The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id: (Ia) (Ib) (Ic) (Id). A particular embodiment is (I).

La présente invention concerne un genre de composés de biaryle qui contiennent au moins un autre noyau. Les composés sont des inhibiteurs de la PDE4 utiles pour le traitement et la prévention d'un accident vasculaire cérébral, d'un infarctus du myocarde et de maladies et troubles d'inflammation cardiovasculaire. Les composés sont représentés par la formule générale Ia, Ib, Ic ou Id : (Ia) (Ib) (Ic) (Id). Un mode de réalisation particulier est (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biaryl pde4 inhibitors for treating pulmonary and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biaryl pde4 inhibitors for treating pulmonary and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl pde4 inhibitors for treating pulmonary and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1866590

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.